Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry

F. Puggioni (Milano, Italy), E. Heffler (Milano, Italy), G. Canonica (Milano, Italy), M. Latorre (Pisa, Italy), F. Blasi (Milano, Italy), P. Paggiaro (Pisa, Italy), M. Caminati (Verona, Italy), G. Senna (Verona, Italy)

Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Session: Asthma: outcomes of clinical trials and cohorts
Session type: Thematic Poster
Number: 4255

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Puggioni (Milano, Italy), E. Heffler (Milano, Italy), G. Canonica (Milano, Italy), M. Latorre (Pisa, Italy), F. Blasi (Milano, Italy), P. Paggiaro (Pisa, Italy), M. Caminati (Verona, Italy), G. Senna (Verona, Italy). Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry. 4255

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: